Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2
Open Access
- 13 March 2022
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 77, 103934
Abstract
No abstract availableKeywords
All Related Versions
This publication has 41 references indexed in Scilit:
- Prospective mapping of viral mutations that escape antibodies used to treat COVID-19Science, 2021
- IgA dominates the early neutralizing antibody response to SARS-CoV-2Science Translational Medicine, 2021
- Syncytia formation by SARS‐CoV‐2‐infected cellsThe EMBO Journal, 2020
- SARS-CoV-2 neutralizing antibody structures inform therapeutic strategiesNature, 2020
- A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populationsScience Translational Medicine, 2020
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spikeNature, 2020
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformationScience, 2020
- GISAID: Global initiative on sharing all influenza data – from vision to realityEurosurveillance, 2017
- Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal AntibodiesPLOS Pathogens, 2015
- Efficient generation of human IgA monoclonal antibodiesJournal of Immunological Methods, 2015